Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Rapamycin research

New studies, reviews and preprints that mention Rapamycin. Linked by keyword: a study can mention a treatment without testing it.

AnimalsStudy · Signal transduction and targeted therapy · Oct 28, 2026

Ginseng compound Rb1 eased signs of aging in the uterus in lab tests

Researchers found that Rb1 reduced aging signs in uterus lining cells and mouse uteruses. This does not show Rb1 helps aging uteruses in people.

Summary of earlier studiesReview · Current issues in molecular biology · Oct 27, 2026

Three common treatments and their possible links to aging and heart health

This review summarizes earlier studies on metformin, SGLT2 inhibitors, and fasting, and suggests a plan for using them together. It notes that key trials for fasting and for metformin in people without diabetes are missing.

Summary of earlier studiesReview · International journal of molecular sciences · Oct 27, 2026

How aging-like cell stress may affect the eye's surface

This review summarizes earlier studies on senescence, a state where cells stop dividing and release inflammatory signals. It suggests this state can help or harm the eye's surface, depending on the situation.

Summary of earlier studiesReview · Developmental biology · Oct 27, 2026

Hemocytes as nutrient-sensing regulators of immune function, lifespan, and intergenerational fitness in Drosophila melanogaster.

Hemocytes are the primary cellular components of the innate immune system in Drosophila melanogaster and share functional and molecular characteristics with vertebrate myeloid cells.

AnimalsLab or animal study · ACS chemical neuroscience · Oct 23, 2026

Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular…

Spinal muscular atrophy (SMA) is a severe neuromuscular disorder caused by homozygous deletions or mutations in the SMN1 gene, resulting in reduced levels of the ubiquitously expressed survival motor neuron protein and…

AnimalsStudy · Cell death & disease · Oct 22, 2026

Apelin-13 protected brain cells from aging in cells and mice

Researchers found that apelin-13 helped brain cells resist aging signs by restoring their cleanup process. This work was done in cells and mice, so it does not show the same effect in people.

Preprint · bioRxiv · Oct 22, 2026

A prediction-interval framework for identifying outlier control cohorts in lifespan studies

Control cohorts anchor the interpretation of lifespan-extending interventions, yet their lifespans vary even under identical experimental conditions.

Summary of earlier studiesReview · Pharmacological reviews · Oct 16, 2026

Harnessing autophagy and its transcriptional regulation in tumorigenesis and neurodegeneration: Potential and existing therapeutic strategies.

Autophagy is a fundamental cellular process that maintains homeostasis by degrading and recycling cellular components.

Study · Proceedings of the National Academy of Sciences of the United States of America · Oct 16, 2026

S-adenosyl-L-homocysteine triggers an adaptive response that extends lifespan through the YBT1 ABC transporter.

S-adenosyl-L-methionine (SAM) is a fundamental methyl donor; however, the physiological role of its byproduct and competitive inhibitor, S-adenosyl-L-homocysteine (SAH), remains unclear.

Summary of earlier studiesReview · Progress in neuro-psychopharmacology & biological psychiatry · Oct 15, 2026

A review proposes a link between two brain proteins and aging-related memory loss

This review looks at two brain proteins that help control inhibitory connections between nerve cells. It suggests they may work together in brain aging, but this idea is not yet proven.

AnimalsStudy · GeroScience · Sep 10, 2026

Copper and iron help yeast cells survive in different ways

Researchers studied yeast cells that were short on food. Copper and iron both helped cells survive, but through different cell signals. This is early lab work, so it does not show what happens in people.

PeopleClinical trial · Aging · Apr 6, 2025

Low-dose rapamycin appeared safe over one year in healthy adults

A trial gave people weekly rapamycin or a placebo for 48 weeks and checked side effects and blood tests. Some measures improved in certain groups, but the researchers say more work is needed.